tbuckley/cabot-search huggingface dataset:
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Authors: Radhika Mathur, Yalan Zhang, Matthew R Grimmer, Chibo Hong, Michael Zhang, Saumya Bollam, Kevin Petrecca, Jennifer Clarke, Mitchel S Berger, Joanna J Phillips, Nancy Ann Oberheim-Bush, Annette M Molinaro, Susan M Chang, Joseph F Costello
Journal: Neuro-Oncology (2020)

Emerging data suggest that a subset of patients with diffuse isocitrate dehydrogenase (IDH)-mutant low-grade glioma (LGG) who receive adjuvant temozolomide (TMZ) recur with hypermutation in association with malignant progression to higher-grade tumors. It is currently unclear why some TMZ-treated LGG patients recur with hypermutation while others do not. MGMT encodes O6-methylguanine-DNA methyltransferase, a DNA repair protein that removes cytotoxic and potentially mutagenic lesions induced by TMZ. Here, we hypothesize that epigenetic silencing of MGMT by promoter methylation facilitates TMZ-induced mutagenesis in LGG patients and contributes to development of hypermutation at recurrence.We utilize a quantitative deep sequencing assay to characterize MGMT promoter methylation in 109 surgical tissue specimens from initial tumors and post-treatment recurrences of 37 TMZ-treated LGG patients. We utilize methylation arrays to validate our sequencing assay, RNA sequencing to assess the relationship between methylation and gene expression, and exome sequencing to determine hypermutation status.Methylation level at the MGMT promoter is significantly higher in initial tumors of patients that develop hypermutation at recurrence relative to initial tumors of patients that do not (45.7% vs 34.8%, P = 0.027). Methylation level in initial tumors can predict hypermutation at recurrence in univariate models and multivariate models that incorporate patient age and molecular subtype.These findings reveal a mechanistic basis for observed differences in patient susceptibility to TMZ-driven hypermutation. Furthermore, they establish MGMT promoter methylation level as a potential biomarker to inform clinical management of LGG patients, including monitoring and treatment decisions, by predicting risk of hypermutation at recurrence.
CT-CLASSIFICATION OF DEGENERATED BIOPROSTHETIC LEAFLETS INSIGHTS INTO THE PATHOGENESIS OF VALVE FAILURE
Authors: Illya Pushkar, Chloe Kalish, Joseph Tovar, Run Du, Cesar Staniloae, Alan Vainrib, Homam Ibrahim, Peter Neuberger, Larry Latson, Michael Querijero, Carlos Lengua, Jorge Fuentes, Jorge Fuentes, Muhamed Saric, Mathew Williams, Hasan Jilaihawi, Anna Kapitman
Journal: Journal of the American College of Cardiology (2020)
THE IMPACT OF PERCUTANEOUS CORONARY ANGIOPLASTY TO PREDICT MORTALITY AND NEUROLOGICAL OUTCOME IN OUT-OF-HOSPITAL CARDIAC ARREST PATIENTS WITHOUT ST-SEGMENT ELEVATION
Authors: Junji Mastuda, Momiji Kaede, Shun Nakamura, Masahiko Nakao, Takayuki Niida, Yu Hatano, Tomoyuki Umemoto, Tetsumin Lee, Taishi Yonetsu
Journal: Journal of the American College of Cardiology (2020)
SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
Authors: Lauren Beth Cooper, Lisa Kaltenbach, Hussein Al-Khalidi, Robert Cole, Larry A. Allen, Gregg C. Fonarow, Javed Butler, Nancy M. Albert, David E. Lanfear, Bradi Granger, Robb Kociol, Ileana Pina, Paul Heidenreich, Christopher B. Granger, G. Michael Felker, Eldrin Lewis, Andrew McRae, Adrian Hernandez, Adam DeVore
Journal: Journal of the American College of Cardiology (2020)
Myocardial Injury and Compromised Cardiomyocyte Integrity Following a Marathon Run
Authors: Vincent L. Aengevaeren, Martijn Froeling, Melissa T. Hooijmans, Jithsa R. Monte, Sandra van den Berg-Faay, Maria T.E. Hopman, Gustav J. Strijkers, Aart J. Nederveen, A.J. Bakermans, Thijs M.H. Eijsvogels
Journal: JACC. Cardiovascular imaging (2020)
Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
Authors: Naoshi Nishida, Kazuko Sakai, Masahiro Morita, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Yoriaki Komeda, Mamoru Takenaka, Yasunori Minami, Hiroshi Ida, Kazuomi Ueshima, Kazuto Nishio, Masatoshi Kudo
Journal: Liver Cancer (2020)

Immune checkpoint inhibitors are promising agents for the treatment of hepatocellular carcinomas (HCC) refractory to conventional therapies. To enhance the efficacy of this treatment, immunological and molecular characteristics of HCC with programmed cell death ligand 1 (PD-L1) should be explored.Clinical backgrounds, PD-L1 expression, and the amount of CD8+ tumor-infiltrating mononuclear cells (TIMCs) were analyzed in 154 HCCs. The expression of 3 stem cell markers and co-inhibitory receptors on tumor cells and TIMCs, respectively, were examined by immunohistochemical analysis. Somatic mutations in the 409 cancer-associated genes and TERT promoter were determined; HCCs were classified based on the presence of gene alterations affecting the 8 oncogenic pathways. The results were validated using the dataset from the Cancer Genome Atlas.The expression of PD-L1 in the HCCs was positively correlated with progressive tumor features, the presence of cytokeratin 19 (CK19), Sal-like protein 4 (SALL4), and the mutations of genes involving the phosphatidyl inositol 3-kinase (PI3K)-Akt pathway. Although CD8+ cells were densely infiltrated in PD-L1-positive tumors, these TIMCs frequently expressed multiple co-inhibitory receptors. However, a subset of PD-L1-positive tumors characterized by activating mutations of the PI3K-Akt pathway showed a low degree of TIMCs. Conversely, PD-L1-negative HCCs were associated with mutations in the β-catenin pathway and a small number of TIMCs, although the expression of co-inhibitory receptors was rare.PD-L1-positive HCCs frequently showed an inflamed phenotype with stem cell features; a subset of PD-L1-positive HCCs with mutations in the PI3K-Akt pathway showed a non-inflamed phenotype. In HCCs with dense infiltration of TIMCs, CD8+ cells expressed multiple co-inhibitory receptors, suggesting T cell exhaustion. On the other hand, PD-L1-negative HCCs showed mutations leading to β-catenin activation and exhibited a non-inflamed background. These characteristics should be taken into consideration for developing novel combination therapies using immune checkpoint inhibitors.
CLO20-030: Sex-Based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma
Authors: Andrew R. Barsky, Christopher A. Ahern, Sriram Venigalla, Vivek Verma, Emily J. Anstadt, Christopher M. Wright, Ethan B. Ludmir, Christopher G. Berlind, William D. Lindsay, Surbhi Grover, Keith A. Cengel, Charles B. Simone
Journal: Journal of the National Comprehensive Cancer Network (2020)
CT VERSUS ECHOCARDIOGRAPHIC STROKE VOLUME INDEX COMPARED TO INVASIVELY DERIVED CARDIAC INDEX TO ASSESS FLOW IN PATIENTS WITH AORTIC STENOSIS
Authors: Rick Gaines, Ramy Mando, Craig Tucker, Saba Assar, Aimee Hite, George S. Hanzel, Michael Gallagher, Francis Shannon, Amr E. Abbas
Journal: Journal of the American College of Cardiology (2020)
Covid-19: junior doctor calls on colleagues to gather supplies for staff working long hours
Authors: Abi Rimmer
Journal: BMJ (2020)

A junior doctor has called on her colleagues to gather supplies that will help healthcare professionals working long hours during the covid-19 outbreak.

Josie Cheetham, chair of the BMA’s Junior Doctors Committee in Wales, shared on Twitter the details of a supply box that she had put together for doctors who were too tired to travel home.

“It contained supplies typically needed after/between work shifts, when staff unexpectedly need to stay on site between shifts,” she wrote. “My hope was that the box allows doctors to meet personal hygiene needs …
Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37–43
Authors: Charlène Telliam, Charles Thivolet
Journal: Diabetes Care (2020)

In the January 2020 issue of Diabetes Care , Soupal et al. (1) provided convincing evidence that continuous glucose monitoring (CGM) by itself is superior to self-monitoring of blood glucose in reducing HbA1c and hypoglycemia, whatever the type of insulin delivery, i.e., continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI). Although we agree with the conclusions that CGM is superior to self-monitoring of blood glucose in reducing hypoglycemia, with comparable time below range for MDI and CSII (5.5% and 5.3%, respectively, in their article), we would like to draw …
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
Authors: Rachael Pung, Calvin J Chiew, Barnaby E Young, Sarah Chin, Mark I-C Chen, Hannah E Clapham, Alex R Cook, Sebastian Maurer-Stroh, Matthias P H S Toh, Cuiqin Poh, Mabel Low, Joshua Lum, Valerie T J Koh, Tze M Mak, Lin Cui, Raymond V T P Lin, Derrick Heng, Yee-Sin Leo, David C Lye, Vernon J M Lee, Kai-qian Kam, Shirin Kalimuddin, Seow Yen Tan, Jiashen Loh, Koh Cheng Thoon, Shawn Vasoo, Wei Xin Khong, Nur-Afidah Suhaimi, Sherlynn JH Chan, Emma Zhang, Olivia Oh, Albert Ty, Charlene Tow, Yi Xian Chua, Wei Liang Chaw, Yixiang Ng, Farid Abdul-Rahman, Shafiq Sahib, Zheng Zhao, Cheryl Tang, Constance Low, Ee Hui Goh, Georgina Lim, Yan'an Hou, Imran Roshan, James Tan, Kelly Foo, Khine Nandar, Lalitha Kurupatham, Pei Pei Chan, Pream Raj, Yijun Lin, Zubaidah Said, Anne Lee, Cherie See, Jessey Markose, Joanna Tan, Guanhao Chan, Wanhan See, Xinyi Peh, Vincent Cai, Wen Kai Chen, Zongbin Li, Roy Soo, Angela LP Chow, Wycliffe Wei, Aysha Farwin, Li Wei Ang
Journal: The Lancet (2020)

Three clusters of coronavirus disease 2019 (COVID-19) linked to a tour group from China, a company conference, and a church were identified in Singapore in February, 2020.We gathered epidemiological and clinical data from individuals with confirmed COVID-19, via interviews and inpatient medical records, and we did field investigations to assess interactions and possible modes of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Open source reports were obtained for overseas cases. We reported the median (IQR) incubation period of SARS-CoV-2.As of Feb 15, 2020, 36 cases of COVID-19 were linked epidemiologically to the first three clusters of circumscribed local transmission in Singapore. 425 close contacts were quarantined. Direct or prolonged close contact was reported among affected individuals, although indirect transmission (eg, via fomites and shared food) could not be excluded. The median incubation period of SARS-CoV-2 was 4 days (IQR 3-6). The serial interval between transmission pairs ranged between 3 days and 8 days.SARS-CoV-2 is transmissible in community settings, and local clusters of COVID-19 are expected in countries with high travel volume from China before the lockdown of Wuhan and institution of travel restrictions. Enhanced surveillance and contact tracing is essential to minimise the risk of widespread transmission in the community.None.
Twitter Journal Clubs
Authors: Roxana Daneshjou, Adewole S. Adamson
Journal: JAMA Dermatology (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
EARLY RESUMPTION OF CANCER TREATMENT AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT ON CARDIOVASCULAR OUTCOMES
Authors: Teodora Donisan, Dinu Balanescu, Moez Aziz, Juhee Song, William Ntim, Nicolas Palaskas, Juan C. Lopez-Mattei, Peter Y. Kim, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Anita Deswal, Cezar Iliescu
Journal: Journal of the American College of Cardiology (2020)
Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis
Authors: Kiyoharu Fukushima, Takashi Satoh, Fuminori Sugihara, Yuki Sato, Toru Okamoto, Yuichi Mitsui, Sachiyo Yoshio, Songling Li, Satoshi Nojima, Daisuke Motooka, Shota Nakamura, Hiroshi Kida, Daron M. Standley, Eiichi Morii, Tatsuya Kanto, Motoko Yanagita, Yoshiharu Matsuura, Takashi Nagasawa, Atsushi Kumanogoh, Shizuo Akira
Journal: Immunity (2020)
UNINTERRUPTED VS. INTERRUPTED NOVEL ORAL ANTICOAGULANT (NOAC) DOSING STRATEGY BEFORE CATHETER ABLATION OF ATRIAL FIBRILLATION: A METANALYSIS OF RANDOMIZED CONTROLLED TRIALS FOR PERIPROCEDURAL COMPLICATIONS
Authors: Indranill Basu Ray, Dibbendhu Khanra, Adedayo Adeboye, Afamefuna Onoaura
Journal: Journal of the American College of Cardiology (2020)
Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics
Authors: Gordon I. Smith, David C. Polidori, Mihoko Yoshino, Monica L. Kearney, Bruce W. Patterson, Bettina Mittendorfer, Samuel Klein
Journal: Journal of Clinical Investigation (2020)

BACKGROUNDInsulin is a key regulator of metabolic function. The effects of excess adiposity, insulin resistance, and hepatic steatosis on the complex integration of insulin secretion and hepatic and extrahepatic tissue extraction are not clear.METHODSA hyperinsulinemic-euglycemic clamp and a 3-hour oral glucose tolerance test were performed to evaluate insulin sensitivity and insulin kinetics after glucose ingestion in 3 groups: (a) lean subjects with normal intrahepatic triglyceride (IHTG) and glucose tolerance (lean-NL; n = 14), (b) obese subjects with normal IHTG and glucose tolerance (obese-NL; n = 24), and (c) obese subjects with nonalcoholic fatty liver disease (NAFLD) and prediabetes (obese-NAFLD; n = 22).RESULTSInsulin sensitivity progressively decreased and insulin secretion progressively increased from the lean-NL to the obese-NL to the obese-NAFLD groups. Fractional hepatic insulin extraction progressively decreased from the lean-NL to the obese-NL to the obese-NAFLD groups, whereas total hepatic insulin extraction (molar amount removed) was greater in the obese-NL and obese-NAFLD subjects than in the lean-NL subjects. Insulin appearance in the systemic circulation and extrahepatic insulin extraction progressively increased from the lean-NL to the obese-NL to the obese-NAFLD groups. Total hepatic insulin extraction plateaued at high rates of insulin delivery, whereas the relationship between systemic insulin appearance and total extrahepatic extraction was linear.CONCLUSIONHyperinsulinemia after glucose ingestion in obese-NL and obese-NAFLD is due to an increase in insulin secretion, without a decrease in total hepatic or extrahepatic insulin extraction. However, the liver's maximum capacity to remove insulin is limited because of a saturable extraction process. The increase in insulin delivery to the liver and extrahepatic tissues in obese-NAFLD is unable to compensate for the increase in insulin resistance, resulting in impaired glucose homeostasis.TRIAL REGISTRATIONClinicalTrials.gov NCT02706262.FUNDINGNIH grants DK56341 (Nutrition Obesity Research Center), DK052574 (Digestive Disease Research Center), RR024992 (Clinical and Translational Science Award), and T32 DK007120 (a T32 Ruth L. Kirschstein National Research Service Award); the American Diabetes Foundation (1-18-ICTS-119); Janssen Research & Development; and the Pershing Square Foundation.
ECPELLA SUPPORT STRATEGY FOR THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK DUE TO PAPILLARY MUSCLE RUPTURE
Authors: Emmanuel Ekanem, Raghav Gattani, Hooman Bakhshi, Behnam Tehrani, Matthew William Sherwood, Kelly Epps, Abdulla Damluji, Carolyn Rosner, Alexander George Truesdell, Christopher R. DeFilippi, Shashank Sinha, Wayne B. Batchelor
Journal: Journal of the American College of Cardiology (2020)
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
Authors: G. Lamberti, L.F. Spurr, Y. Li, B. Ricciuti, G. Recondo, R. Umeton, M. Nishino, L.M. Sholl, M.L. Meyerson, A.D. Cherniack, M.M. Awad
Journal: Annals of Oncology (2020)
IS THERE A GENDER DISPARITY IN CHARACTERISTICS AND OUTCOMES FOR PATIENTS OVER 85 YEARS PRESENTING WITH NON-ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI)?
Authors: Alexandra Murphy, Anoop Koshy, Phelia Kunniardy, Georgie Meehan, Jay Ramchand, H.M. Omar Farouque, David Clark, Matias Yudi
Journal: Journal of the American College of Cardiology (2020)
EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: PRIMARY RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (BEIJERINCK)
Authors: Franck Boccara, Princy Kumar, Bruno Caramelli, Alexandra Calmy, J. Antonio G. Lopez, Sarah Bray, Marcoli Cyrille, Robert S. Rosenson
Journal: Journal of the American College of Cardiology (2020)
29P FGFR1-4 high mRNA expression (mRNAh) as predictive biomarker for FGFR inhibitors in breast cancer (BC)
Authors: C. Hierro, M. Sánchez-Guixé, J. Jiménez, E. Garralda, C. Saura, P. Nuciforo, A. Vivancos, J. Tabernero, J. Rodon, V. Serra
Journal: Annals of Oncology (2020)
CHANGES IN PLASMA LEVELS OF INFLAMMATORY MEDIATORS BETWEEN LOW AND HIGH AIR POLLUTION SEASONS IN HEALTHY SUBJECTS AND ACUTE CORONARY SYNDROME PATIENTS
Authors: Nicolas Saavedra, Fernando Tomas Lanas, Kathleen Saavedra, Katherine Andara, Montserrat Hevia, Pamela Seron, Luis A. Salazar
Journal: Journal of the American College of Cardiology (2020)
Patient attitude and survival in advanced non-small cell lung cancer (NSCLC): Results of a prospective observational study
Authors: S. Altug, L. Wang, D. Chu, K. Park, H. Hsu, G. Cok, J. Roubec, S. Patil, D. Damyanov, W. Reece
Journal: Journal of Clinical Oncology (2006)

7148 Background: A physician’s ability to accurately identify a patient’s attitude toward treatment is critical. The primary objective of this study (B9E-AA-JHSH) was to evaluate patient attitudes as predictors of survival independently of currently known predictive variables, and secondarily, whether physician-assessed patient attitudes differed from patient-assessed attitudes. Methods: This was a non-interventional, prospective, observational study of patients from 19 countries of Asia, Central Eastern Europe, and Latin America. Eligible patients had stage IIIB/IV NSCLC not amenable to curative surgery/radiotherapy, gemcitabine and cis/carboplatin as part of treatment, and were chemonaive. Physicians and patients used a 7-item questionnaire to assign patient attitudes to 1 of 4 categories using a pre-defined algorithm: A = Cure; B = Maximum extension of survival with acceptance of high toxicity; C = Maximum extension of survival only if coupled with normal lifestyle; and D = Symptom relief. Enrolled patients were followed until 18 months from enrolment, death, or loss to follow up. Results: From Sept 2002 to Dec 2003, 1,985 patients were enrolled; the majority were male (73.4%), &lt;70 yrs (83.9%), and had stage IV disease (79.2%), PS 0–1 (79.2%), and tumor-related symptoms (89.2%). Distribution of patient-assessed attitudes were A = 0%, B = 55%, C = 25%, and D = 20%. From category B-D, median survival (B = 14.6 months, C = 13.5, D = 12.5) and 1-year survival (B = 57.6%, C = 56.2%, D = 51.2%) both decreased but the differences were not statistically significant. Adjustment for known predictive variables eliminated this decreasing trend. Physician-assessed patient attitudes were lower than patient-assessed attitudes (p &lt; .0001); however, the difference was less for patients with disease-related symptoms (p = .03). Conclusions: This is the largest analysis to date of patient attitudes when treated with gemcitabine and cis/carboplatin. Patient attitudes were not significant predictors of survival; however, physicians do underestimate patients’ desire for extended survival compared to symptom relief. Also, it was interesting to see a comparatively longer median and 1-year survival in routine practice compared to reports in clinical trial settings. [Table: see text]
PLASMA PROTEIN SCANNING AS A NEW TOOL IN PREVENTIVE CARDIOLOGY
Authors: Rachel Ostroff, Claudia Langenberg, Nicholas Wareham, Peter Ganz, Mika Kivimaki, Claude Bouchard, Christian Jonasson, Leigh Alexander, Jessica Chadwick, Gargi Datta, Yolanda Hagar, Michael Hinterberg, Stephen A. Williams
Journal: Journal of the American College of Cardiology (2020)
IMPACT OF RESIDUAL CHOLESTEROL ON PROGNOSIS IN CORONARY ARTERY DISEASE PATIENTS UNDER DIFFERENT GLUCOSE METABOLISM STATUS
Authors: Ye-Xuan Cao, Jing-Lu Jin, Hui-Wen Zhang, Hui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, Rui-Xia Xu, Cheng-Gang Zhu, Ying Gao, Qian Dong, Jing Sun, Chuan-Jue Cui, Jian-Jun Li
Journal: Journal of the American College of Cardiology (2020)
FIBROUS CAP COMPOSITION IN PATIENTS WITH ACUTE OR CHRONIC CORONARY SYNDROMES: INSIGHTS FROM INTRAVASCULAR POLARIMETRY
Authors: Kenichiro Otsuka, Martin Villiger, Laurens van Zandvoort, Tara Neleman, Antonios Karanasos, Jouke Dijkstra, Seemantini Nadkarni, Evelyn Regar, Joost Daemen, Brett Bouma
Journal: Journal of the American College of Cardiology (2020)
IMPACT OF PHYSIOLOGIC PALLIATION STRATEGY ON OUTCOMES IN THE SYMPTOMATIC NEONATE WITH TETRALOGY OF FALLOT: INSIGHTS FROM THE CONGENITAL CATHETERIZATION RESEARCH COLLABORATIVE
Authors: Mark Aaron Law, Andrew C. Glatz, Shabana Shahanavaz, Jeffrey Zampi, George Nicholson, Jeffery Meadows, Bryan Goldstein, Holly Bauser-Heaton, Christopher Petit, Paul Chai, Jennifer C. Romano, Christopher Mascio, Christopher Caldarone, Courtney McCracken, Mike Kelleman, Lindsay Eilers, Steven Healan, Justin Smith, Ivor Asztalos, Alicia Kamsheh, Sarina Juma, Kristal Hock, Joelle Pettus, Amy Pajk, Athar M. Qureshi
Journal: Journal of the American College of Cardiology (2020)